Shopping Cart 0
Cart Subtotal
USD 0

Curetis NV (CURE) - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 2250

Details

Summary

Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company provides diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for cartridges, diseases such as implant and tissue infections, and pneumonia; and also used in the laboratory for multiplex polymerase chain reaction pcr diagnostics. Curetis serves medical, healthcare companies, biotechnology, contract research and pharmaceutical companies, among others. The company sells its products through a network of distributors located across Germany. It has its operations in in France, Switzerland, Netherlands, the UK, the US and Germany. Curetis is headquartered in Stuttgart, Germany.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Curetis NV

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Curetis NV Company Overview

Curetis NV Company Snapshot

Curetis NV Pipeline Products and Ongoing Clinical Trials Overview

Curetis NV-Pipeline Analysis Overview

Curetis NV-Key Facts

Curetis NV-Major Products and Services

Curetis NV Pipeline Products by Development Stage

Curetis NV Ongoing Clinical Trials by Trial Status

Curetis NV Pipeline Products Overview

Gyronimo Analyzer

Gyronimo Analyzer Product Overview

Next Generation Unyvero Implant & Tissue Infections Cartridge

Next Generation Unyvero Implant & Tissue Infections Cartridge Product Overview

Next-Generation Sequencing Assay-Microbial Infections

Next-Generation Sequencing Assay-Microbial Infections Product Overview

Pneumocystis Jirovecii Assay

Pneumocystis Jirovecii Assay Product Overview

Unyvero A30 RQ Application Cartridge

Unyvero A30 RQ Application Cartridge Product Overview

Unyvero A50-CAI

Unyvero A50-CAI Product Overview

Unyvero A50-IJI

Unyvero A50-IJI Product Overview

Unyvero A50-SHR

Unyvero A50-SHR Product Overview

Unyvero A50-XRP

Unyvero A50-XRP Product Overview

Unyvero A50 Analyzer

Unyvero A50 Analyzer Product Overview

UNYVERO ANALYZER A30-CNS Infection

UNYVERO ANALYZER A30-CNS Infection Product Overview

UNYVERO ANALYZER A30-ICO

UNYVERO ANALYZER A30-ICO Product Overview

UNYVERO ANALYZER A30-RVP

UNYVERO ANALYZER A30-RVP Product Overview

Unyvero Analyzer A30 RQ

Unyvero Analyzer A30 RQ Product Overview

Unyvero Analyzer A30 RQ-Immuno-Compromised Patient Panel

Unyvero Analyzer A30 RQ-Immuno-Compromised Patient Panel Product Overview

Unyvero BCU Cartridge

Unyvero BCU Cartridge Product Overview

Unyvero BCU Cartridge Clinical Trial

Unyvero Cardiology Infection Cartridge

Unyvero Cardiology Infection Cartridge Product Overview

Unyvero CNS Infections Cartridge

Unyvero CNS Infections Cartridge Product Overview

Unyvero Extended LRT Cartridge

Unyvero Extended LRT Cartridge Product Overview

Unyvero HPN Catridge

Unyvero HPN Catridge Product Overview

Unyvero HPN Catridge Clinical Trial

Unyvero i60 Cartridge

Unyvero i60 Cartridge Product Overview

Unyvero IAI Cartridge

Unyvero IAI Cartridge Product Overview

Unyvero Implant And Tissue Infections Cartridge

Unyvero Implant And Tissue Infections Cartridge Product Overview

Unyvero Invasive Joint Infection Cartridge

Unyvero Invasive Joint Infection Cartridge Product Overview

Unyvero Invasive Joint Infection Cartridge Clinical Trial

Unyvero LRT55 Cartridge-Bronchial Lavage Samples

Unyvero LRT55 Cartridge-Bronchial Lavage Samples Product Overview

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples Product Overview

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples Clinical Trial

Unyvero P50 LRT Cartridge

Unyvero P50 LRT Cartridge Product Overview

Unyvero P50 LRT Cartridge Clinical Trial

Unyvero Pediatric Infections Cartridge

Unyvero Pediatric Infections Cartridge Product Overview

Unyvero Rapid Infectious Testing Device

Unyvero Rapid Infectious Testing Device Product Overview

Unyvero Sepsis Host Response Cartridge

Unyvero Sepsis Host Response Cartridge Product Overview

Unyvero Sepsis Host Response Cartridge Clinical Trial

Unyvero Tuberculosis Cartridge

Unyvero Tuberculosis Cartridge Product Overview

Unyvero Urinary Tract Infection Cartridge

Unyvero Urinary Tract Infection Cartridge Product Overview

Curetis NV-Key Competitors

Curetis NV-Key Employees

Curetis NV-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Curetis NV, Recent Developments

Jun 04, 2019: New data on Curetis Unyvero LRT Panel for pneumonia to be presented at ASM Microbe 2019

May 23, 2019: Curetis reports positive results from clinical validation study for U.S. FDA 510(k) submission of Unyvero LRT for BAL Samples

May 21, 2019: Curetis to receive additional EUR 6.5 Million financing from EIB and Yorkville

May 17, 2019: Curetis announces financial results for the first three months of 2019

Apr 11, 2019: Curetis publishes full-year 2018 financial results and updated guidance for 2019

Apr 04, 2019: Curetis study data presented At ECCMID 2019 Confirm Clinical Benefits Of Unyvero Platform

Apr 04, 2019: Curetis: study data presented at ECCMID 2019 Confirm Clinical Benefits of Unyvero Platform

Apr 02, 2019: Curetis introduces Unyvero AMR Atlas to support adoption of rapid DNA testing for antibiotic resistance

Feb 04, 2019: Curetis' partner Beijing Clear Biotech submits filing for Unyvero approval in China

Jan 30, 2019: Curetis' Unyvero application cartridges receive regulatory approvals in Malaysia and Thailand

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Curetis NV Pipeline Products by Equipment Type

Curetis NV Pipeline Products by Development Stage

Curetis NV Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Curetis NV Pipeline Products and Ongoing Clinical Trials Overview

Curetis NV Pipeline Products by Equipment Type

Curetis NV Pipeline Products by Indication

Curetis NV Ongoing Clinical Trials by Trial Status

Curetis NV, Key Facts

Curetis NV, Major Products and Services

Curetis NV Number of Pipeline Products by Development Stage

Curetis NV Pipeline Products Summary by Development Stage

Curetis NV Ongoing Clinical Trials by Trial Status

Curetis NV Ongoing Clinical Trials Summary

Gyronimo Analyzer-Product Status

Gyronimo Analyzer-Product Description

Next Generation Unyvero Implant & Tissue Infections Cartridge-Product Status

Next Generation Unyvero Implant & Tissue Infections Cartridge-Product Description

Next-Generation Sequencing Assay-Microbial Infections-Product Status

Next-Generation Sequencing Assay-Microbial Infections-Product Description

Pneumocystis Jirovecii Assay-Product Status

Pneumocystis Jirovecii Assay-Product Description

Unyvero A30 RQ Application Cartridge-Product Status

Unyvero A30 RQ Application Cartridge-Product Description

Unyvero A50-CAI-Product Status

Unyvero A50-CAI-Product Description

Unyvero A50-IJI-Product Status

Unyvero A50-IJI-Product Description

Unyvero A50-SHR-Product Status

Unyvero A50-SHR-Product Description

Unyvero A50-XRP-Product Status

Unyvero A50-XRP-Product Description

Unyvero A50 Analyzer-Product Status

Unyvero A50 Analyzer-Product Description

UNYVERO ANALYZER A30-CNS Infection-Product Status

UNYVERO ANALYZER A30-CNS Infection-Product Description

UNYVERO ANALYZER A30-ICO-Product Status

UNYVERO ANALYZER A30-ICO-Product Description

UNYVERO ANALYZER A30-RVP-Product Status

UNYVERO ANALYZER A30-RVP-Product Description

Unyvero Analyzer A30 RQ-Product Status

Unyvero Analyzer A30 RQ-Product Description

Unyvero Analyzer A30 RQ-Immuno-Compromised Patient Panel-Product Status

Unyvero Analyzer A30 RQ-Immuno-Compromised Patient Panel-Product Description

Unyvero BCU Cartridge-Product Status

Unyvero BCU Cartridge-Product Description

Unyvero BCU Cartridge-External, Prospective, Multicenter Evaluation Comparing the Performance of the BCU Application Cartridge against the Performance of Conventional Microbiology Work-Up

Unyvero Cardiology Infection Cartridge-Product Status

Unyvero Cardiology Infection Cartridge-Product Description

Unyvero CNS Infections Cartridge-Product Status

Unyvero CNS Infections Cartridge-Product Description

Unyvero Extended LRT Cartridge-Product Status

Unyvero Extended LRT Cartridge-Product Description

Unyvero HPN Catridge-Product Status

Unyvero HPN Catridge-Product Description

Unyvero HPN Catridge-Impact of a Strategy Based on the Unyvero Testing System on Appropriate and Targeted Antimicrobial Treatment in Patients with Suspected VAP or HAP Requiring Mechanical Ventilation: A Randomized Controlled Unblinded Trial

Unyvero i60 Cartridge-Product Status

Unyvero i60 Cartridge-Product Description

Unyvero IAI Cartridge-Product Status

Unyvero IAI Cartridge-Product Description

Unyvero Implant And Tissue Infections Cartridge-Product Status

Unyvero Implant And Tissue Infections Cartridge-Product Description

Unyvero Invasive Joint Infection Cartridge-Product Status

Unyvero Invasive Joint Infection Cartridge-Product Description

Unyvero Invasive Joint Infection Cartridge-Clinical Study of Unyvero IJI Cartridge for the Detection of Invasive Joint Infections

Unyvero LRT55 Cartridge-Bronchial Lavage Samples-Product Status

Unyvero LRT55 Cartridge-Bronchial Lavage Samples-Product Description

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples-Product Status

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples-Product Description

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples-Clinical CE Performance Evaluation of Unyvero P55 Pneumonia Application

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples-Impact of a Strategy Based on the Unyvero Testing System on Appropriate and Targeted Antimicrobial Treatment in Patients with Suspected VAP or HAP Requiring Mechanical Ventilation: A Randomized Controlled Unblinded Trial

Unyvero P50 LRT Cartridge-Product Status

Unyvero P50 LRT Cartridge-Product Description

Unyvero P50 LRT Cartridge-Impact of a Strategy Based on the Unyvero Testing System on Appropriate and Targeted Antimicrobial Treatment in Patients with Suspected VAP or HAP Requiring Mechanical Ventilation: A Randomized Controlled Unblinded Trial

Unyvero Pediatric Infections Cartridge-Product Status

Unyvero Pediatric Infections Cartridge-Product Description

Unyvero Rapid Infectious Testing Device-Product Status

Unyvero Rapid Infectious Testing Device-Product Description

Unyvero Sepsis Host Response Cartridge-Product Status

Unyvero Sepsis Host Response Cartridge-Product Description

Unyvero Sepsis Host Response Cartridge-Bedside Versus Standard Microbiological Blood Culture Diagnostics: BEMIDIA Study

Unyvero Tuberculosis Cartridge-Product Status

Unyvero Tuberculosis Cartridge-Product Description

Unyvero Urinary Tract Infection Cartridge-Product Status

Unyvero Urinary Tract Infection Cartridge-Product Description

Curetis NV, Key Employees

Curetis NV, Other Locations

Curetis NV, Subsidiaries

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Curetis NV, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

AMODIA Bioservice GmbH

OpGen Inc

Roche Innovatis AG

Biomed Labordiagnostik GmbH

Company Profile

Company Profile Title

Summary

Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company provides diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for cartridges, diseases such as implant and tissue infections, and pneumonia; and also used in the laboratory for multiplex polymerase chain reaction pcr diagnostics. Curetis serves medical, healthcare companies, biotechnology, contract research and pharmaceutical companies, among others. The company sells its products through a network of distributors located across Germany. It has its operations in in France, Switzerland, Netherlands, the UK, the US and Germany. Curetis is headquartered in Stuttgart, Germany.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Curetis NV

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Curetis NV Company Overview

Curetis NV Company Snapshot

Curetis NV Pipeline Products and Ongoing Clinical Trials Overview

Curetis NV-Pipeline Analysis Overview

Curetis NV-Key Facts

Curetis NV-Major Products and Services

Curetis NV Pipeline Products by Development Stage

Curetis NV Ongoing Clinical Trials by Trial Status

Curetis NV Pipeline Products Overview

Gyronimo Analyzer

Gyronimo Analyzer Product Overview

Next Generation Unyvero Implant & Tissue Infections Cartridge

Next Generation Unyvero Implant & Tissue Infections Cartridge Product Overview

Next-Generation Sequencing Assay-Microbial Infections

Next-Generation Sequencing Assay-Microbial Infections Product Overview

Pneumocystis Jirovecii Assay

Pneumocystis Jirovecii Assay Product Overview

Unyvero A30 RQ Application Cartridge

Unyvero A30 RQ Application Cartridge Product Overview

Unyvero A50-CAI

Unyvero A50-CAI Product Overview

Unyvero A50-IJI

Unyvero A50-IJI Product Overview

Unyvero A50-SHR

Unyvero A50-SHR Product Overview

Unyvero A50-XRP

Unyvero A50-XRP Product Overview

Unyvero A50 Analyzer

Unyvero A50 Analyzer Product Overview

UNYVERO ANALYZER A30-CNS Infection

UNYVERO ANALYZER A30-CNS Infection Product Overview

UNYVERO ANALYZER A30-ICO

UNYVERO ANALYZER A30-ICO Product Overview

UNYVERO ANALYZER A30-RVP

UNYVERO ANALYZER A30-RVP Product Overview

Unyvero Analyzer A30 RQ

Unyvero Analyzer A30 RQ Product Overview

Unyvero Analyzer A30 RQ-Immuno-Compromised Patient Panel

Unyvero Analyzer A30 RQ-Immuno-Compromised Patient Panel Product Overview

Unyvero BCU Cartridge

Unyvero BCU Cartridge Product Overview

Unyvero BCU Cartridge Clinical Trial

Unyvero Cardiology Infection Cartridge

Unyvero Cardiology Infection Cartridge Product Overview

Unyvero CNS Infections Cartridge

Unyvero CNS Infections Cartridge Product Overview

Unyvero Extended LRT Cartridge

Unyvero Extended LRT Cartridge Product Overview

Unyvero HPN Catridge

Unyvero HPN Catridge Product Overview

Unyvero HPN Catridge Clinical Trial

Unyvero i60 Cartridge

Unyvero i60 Cartridge Product Overview

Unyvero IAI Cartridge

Unyvero IAI Cartridge Product Overview

Unyvero Implant And Tissue Infections Cartridge

Unyvero Implant And Tissue Infections Cartridge Product Overview

Unyvero Invasive Joint Infection Cartridge

Unyvero Invasive Joint Infection Cartridge Product Overview

Unyvero Invasive Joint Infection Cartridge Clinical Trial

Unyvero LRT55 Cartridge-Bronchial Lavage Samples

Unyvero LRT55 Cartridge-Bronchial Lavage Samples Product Overview

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples Product Overview

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples Clinical Trial

Unyvero P50 LRT Cartridge

Unyvero P50 LRT Cartridge Product Overview

Unyvero P50 LRT Cartridge Clinical Trial

Unyvero Pediatric Infections Cartridge

Unyvero Pediatric Infections Cartridge Product Overview

Unyvero Rapid Infectious Testing Device

Unyvero Rapid Infectious Testing Device Product Overview

Unyvero Sepsis Host Response Cartridge

Unyvero Sepsis Host Response Cartridge Product Overview

Unyvero Sepsis Host Response Cartridge Clinical Trial

Unyvero Tuberculosis Cartridge

Unyvero Tuberculosis Cartridge Product Overview

Unyvero Urinary Tract Infection Cartridge

Unyvero Urinary Tract Infection Cartridge Product Overview

Curetis NV-Key Competitors

Curetis NV-Key Employees

Curetis NV-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Curetis NV, Recent Developments

Jun 04, 2019: New data on Curetis Unyvero LRT Panel for pneumonia to be presented at ASM Microbe 2019

May 23, 2019: Curetis reports positive results from clinical validation study for U.S. FDA 510(k) submission of Unyvero LRT for BAL Samples

May 21, 2019: Curetis to receive additional EUR 6.5 Million financing from EIB and Yorkville

May 17, 2019: Curetis announces financial results for the first three months of 2019

Apr 11, 2019: Curetis publishes full-year 2018 financial results and updated guidance for 2019

Apr 04, 2019: Curetis study data presented At ECCMID 2019 Confirm Clinical Benefits Of Unyvero Platform

Apr 04, 2019: Curetis: study data presented at ECCMID 2019 Confirm Clinical Benefits of Unyvero Platform

Apr 02, 2019: Curetis introduces Unyvero AMR Atlas to support adoption of rapid DNA testing for antibiotic resistance

Feb 04, 2019: Curetis' partner Beijing Clear Biotech submits filing for Unyvero approval in China

Jan 30, 2019: Curetis' Unyvero application cartridges receive regulatory approvals in Malaysia and Thailand

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Curetis NV Pipeline Products by Equipment Type

Curetis NV Pipeline Products by Development Stage

Curetis NV Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Curetis NV Pipeline Products and Ongoing Clinical Trials Overview

Curetis NV Pipeline Products by Equipment Type

Curetis NV Pipeline Products by Indication

Curetis NV Ongoing Clinical Trials by Trial Status

Curetis NV, Key Facts

Curetis NV, Major Products and Services

Curetis NV Number of Pipeline Products by Development Stage

Curetis NV Pipeline Products Summary by Development Stage

Curetis NV Ongoing Clinical Trials by Trial Status

Curetis NV Ongoing Clinical Trials Summary

Gyronimo Analyzer-Product Status

Gyronimo Analyzer-Product Description

Next Generation Unyvero Implant & Tissue Infections Cartridge-Product Status

Next Generation Unyvero Implant & Tissue Infections Cartridge-Product Description

Next-Generation Sequencing Assay-Microbial Infections-Product Status

Next-Generation Sequencing Assay-Microbial Infections-Product Description

Pneumocystis Jirovecii Assay-Product Status

Pneumocystis Jirovecii Assay-Product Description

Unyvero A30 RQ Application Cartridge-Product Status

Unyvero A30 RQ Application Cartridge-Product Description

Unyvero A50-CAI-Product Status

Unyvero A50-CAI-Product Description

Unyvero A50-IJI-Product Status

Unyvero A50-IJI-Product Description

Unyvero A50-SHR-Product Status

Unyvero A50-SHR-Product Description

Unyvero A50-XRP-Product Status

Unyvero A50-XRP-Product Description

Unyvero A50 Analyzer-Product Status

Unyvero A50 Analyzer-Product Description

UNYVERO ANALYZER A30-CNS Infection-Product Status

UNYVERO ANALYZER A30-CNS Infection-Product Description

UNYVERO ANALYZER A30-ICO-Product Status

UNYVERO ANALYZER A30-ICO-Product Description

UNYVERO ANALYZER A30-RVP-Product Status

UNYVERO ANALYZER A30-RVP-Product Description

Unyvero Analyzer A30 RQ-Product Status

Unyvero Analyzer A30 RQ-Product Description

Unyvero Analyzer A30 RQ-Immuno-Compromised Patient Panel-Product Status

Unyvero Analyzer A30 RQ-Immuno-Compromised Patient Panel-Product Description

Unyvero BCU Cartridge-Product Status

Unyvero BCU Cartridge-Product Description

Unyvero BCU Cartridge-External, Prospective, Multicenter Evaluation Comparing the Performance of the BCU Application Cartridge against the Performance of Conventional Microbiology Work-Up

Unyvero Cardiology Infection Cartridge-Product Status

Unyvero Cardiology Infection Cartridge-Product Description

Unyvero CNS Infections Cartridge-Product Status

Unyvero CNS Infections Cartridge-Product Description

Unyvero Extended LRT Cartridge-Product Status

Unyvero Extended LRT Cartridge-Product Description

Unyvero HPN Catridge-Product Status

Unyvero HPN Catridge-Product Description

Unyvero HPN Catridge-Impact of a Strategy Based on the Unyvero Testing System on Appropriate and Targeted Antimicrobial Treatment in Patients with Suspected VAP or HAP Requiring Mechanical Ventilation: A Randomized Controlled Unblinded Trial

Unyvero i60 Cartridge-Product Status

Unyvero i60 Cartridge-Product Description

Unyvero IAI Cartridge-Product Status

Unyvero IAI Cartridge-Product Description

Unyvero Implant And Tissue Infections Cartridge-Product Status

Unyvero Implant And Tissue Infections Cartridge-Product Description

Unyvero Invasive Joint Infection Cartridge-Product Status

Unyvero Invasive Joint Infection Cartridge-Product Description

Unyvero Invasive Joint Infection Cartridge-Clinical Study of Unyvero IJI Cartridge for the Detection of Invasive Joint Infections

Unyvero LRT55 Cartridge-Bronchial Lavage Samples-Product Status

Unyvero LRT55 Cartridge-Bronchial Lavage Samples-Product Description

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples-Product Status

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples-Product Description

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples-Clinical CE Performance Evaluation of Unyvero P55 Pneumonia Application

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples-Impact of a Strategy Based on the Unyvero Testing System on Appropriate and Targeted Antimicrobial Treatment in Patients with Suspected VAP or HAP Requiring Mechanical Ventilation: A Randomized Controlled Unblinded Trial

Unyvero P50 LRT Cartridge-Product Status

Unyvero P50 LRT Cartridge-Product Description

Unyvero P50 LRT Cartridge-Impact of a Strategy Based on the Unyvero Testing System on Appropriate and Targeted Antimicrobial Treatment in Patients with Suspected VAP or HAP Requiring Mechanical Ventilation: A Randomized Controlled Unblinded Trial

Unyvero Pediatric Infections Cartridge-Product Status

Unyvero Pediatric Infections Cartridge-Product Description

Unyvero Rapid Infectious Testing Device-Product Status

Unyvero Rapid Infectious Testing Device-Product Description

Unyvero Sepsis Host Response Cartridge-Product Status

Unyvero Sepsis Host Response Cartridge-Product Description

Unyvero Sepsis Host Response Cartridge-Bedside Versus Standard Microbiological Blood Culture Diagnostics: BEMIDIA Study

Unyvero Tuberculosis Cartridge-Product Status

Unyvero Tuberculosis Cartridge-Product Description

Unyvero Urinary Tract Infection Cartridge-Product Status

Unyvero Urinary Tract Infection Cartridge-Product Description

Curetis NV, Key Employees

Curetis NV, Other Locations

Curetis NV, Subsidiaries

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Curetis NV, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

AMODIA Bioservice GmbH

OpGen Inc

Roche Innovatis AG

Biomed Labordiagnostik GmbH